-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UfmqWEu/HumaZIv7Yei48QpgV4GLkSITzipskAek5TioWJqY8doiEWu0ZIBUJA7T 8y31Tzm+YqoahpMOgtsvNg== 0001061983-07-000033.txt : 20070802 0001061983-07-000033.hdr.sgml : 20070802 20070802182808 ACCESSION NUMBER: 0001061983-07-000033 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070801 FILED AS OF DATE: 20070802 DATE AS OF CHANGE: 20070802 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CYTOKINETICS INC CENTRAL INDEX KEY: 0001061983 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943291317 BUSINESS ADDRESS: STREET 1: 280 EAST GRAND AVENUE STREET 2: . CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 624-3000 MAIL ADDRESS: STREET 1: 280 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sabry James H CENTRAL INDEX KEY: 0001288858 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50633 FILM NUMBER: 071021721 BUSINESS ADDRESS: BUSINESS PHONE: 650-624-3000 MAIL ADDRESS: STREET 1: 280 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2007-08-01 0 0001061983 CYTOKINETICS INC CYTK 0001288858 Sabry James H 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 1 1 0 0 Executive Chairman Common Stock 2007-08-01 4 M 0 7000 1.2 A 7000 D Common Stock 2007-08-01 4 S 0 7000 5 D 0 D Common Stock 198150 I by Trust Non-Qualified Stock Option (right to buy) 1.2 2007-08-01 4 M 0 7000 0 D 2002-07-10 2012-07-10 Common Stock 7000 182254 D Incentive Stock Option (right to buy) 0.58 1999-09-28 2009-09-28 Common Stock 62500 62500 D Incentive Stock Option (right to buy) 0.58 2000-11-14 2010-11-14 Common Stock 172413 172413 D Incentive Stock Option (right to buy) 1.2 2002-07-10 2012-07-10 Common Stock 83333 83333 D Incentive Stock Option (right to buy) 1.2 2003-05-21 2013-05-21 Common Stock 75000 75000 D Incentive Stock Option (right to buy) 6.5 2004-04-08 2014-03-08 Common Stock 66943 66943 D Incentive Stock Option (right to buy) 6.59 2005-04-11 2015-04-11 Common Stock 15154 15154 D Incentive Stock Option (right to buy) 6.81 2007-04-01 2017-03-14 Common Stock 11091 11091 D Incentive Stock Option (right to buy) 7.15 2006-03-01 2016-03-01 Common Stock 18464 18464 D Non-Qualified Stock Option (right to buy) 6.5 2004-04-08 2014-03-08 Common Stock 19557 19557 D Non-Qualified Stock Option (right to buy) 6.59 2005-04-11 2015-04-11 Common Stock 69846 69846 D Non-Qualified Stock Option (right to buy) 6.81 2007-04-01 2017-03-14 Common Stock 88909 88909 D Non-Qualified Stock Option (right to buy) 7.15 2006-03-01 2016-03-01 Common Stock 131536 131536 D The exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2007. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2007. When the ISO and NQ dated 07/10/02 are combined for a total grant of 300,000 shares, the option is immediately exercisable upon grant and shall vest as to 5,000 shares on 04/15/02 and the balance of 295,000 divided into equal monthly installments thereafter such that the option shall be 100% vested on 03/15/07. This option is immediately exercisable upon grant and shall vest as to 15,625 shares on 05/01/99 and the balance of 46,875 divided into equal monthly installments thereafter such that the option shall be 100% vested on 05/01/02. When the ISO and NQ dated 11/14/00 are combined for a total grant of 250,000 shares, the option is immediately exercisable upon grant and shall vest as to 4,167 shares on 12/14/00 and the balance of 245,833 divided into equal monthly installments thereafter such that the option shall be 100% vested on 11/14/05. This option is immediately exercisable upon grant and shall vest as to 1,563 shares on 04/01/03 and the balance of 73,437 divided into equal monthly installments thereafter such that the option shall be 100% vested on 03/01/07. When the ISO and NQ dated 03/08/04 are combined for a total grant of 86,500 shares, the option shall vest and become exercisable as to 1,802 shares on 04/08/04 and the balance of 84,698 divided into equal monthly installments thereafter such that the option shall be 100% vested on 03/08/08. When the ISO and NQ dated 04/11/05 are combined for a total grant of 85,000 shares, the option shall vest and become exercisable as to 85,000 shares divided into equal monthly installments such that the option shall be 100% vested on 03/01/2009. When the ISO and NQ dated 03/14/2007 are combined for a total grant of 100,000 shares, the option shall vest and become exercisable as to 2,083 shares on 04/01/07 and the balance of 97,917 divided into equal monthly installments thereafter such that the option shall be 100% vested on 03/01/11. When the ISO and NQ dated 03/01/2006 are combined for a total grant of 150,000 shares, the option shall vest and become exercisable as to 150,000 shares divided into equal monthly installments such that the option shall be 100% vested on 03/01/2010. James H. Sabry, M.D., Ph.D. 2007-08-02 -----END PRIVACY-ENHANCED MESSAGE-----